All News

Two independent published trials have validated the performance of an epigenetic test that could provide physicians with a better tool to help eliminate unnecessary repeat prostate biopsies.

The federal system for financing physician training and residency programs needs to be overhauled to ensure that the United States is producing the physicians that the nation needs, according to a new Institute of Medicine (IOM) report that the AUA says makes recommendations that would have a negative effect on teaching hospitals and fails to acknowledge a doctor shortage across all specialties.

This infographic depicts the efforts of several states to boost graduate medical education funding. Is your state among them?

To gain an endocrinologist’s perspective on current issues in testosterone therapy and hypogonadism, Urology Times interviewed Rebecca Z. Sokol MD, MPH, professor of obstetrics and gynecology and medicine at the Keck School of Medicine of the University of Southern California, Los Angeles.

All treatments entail some risk, including T therapy. At this point, there are no compelling data to support the notion that T therapy is associated with CV risks, and there is suggestive evidence it may even be helpful.

As policymakers learn about the burgeoning bottleneck between medical school graduation and graduate medical education, a number of novel approaches to physician training have launched from Sacramento to Jefferson City to Tallahassee. Not surprisingly, many of these solutions pit providers against one another amid concerns about patient safety and the dilution of professional standards.

The FDA has rejected Public Citizen’s petition to have a black box warning placed on the labels of testosterone-containing drugs available in the United States.

A genomic tool for prostate cancer appears to provide physicians and patients with improved decision making about the use of radiation therapy after radical prostatectomy.

A new study showing a survival benefit of more than 1 year with a chemotherapy-hormonal therapy combination given prior to castration resistance is being hailed by a leading prostate cancer expert as possibly representing a “new standard” in care.

This article reviews the evaluation and the medical and surgical management options for patients with what most experts refer to as chronic scrotal content pain.

Symptomatic hypogonadal men treated with clomiphene citrate (Clomid) or testosterone gels report similar satisfaction levels as age-matched men treated with testosterone injections, despite having significantly lower serum total testosterone levels, according to the findings of a recent retrospective study from Baylor College of Medicine, Houston.

Testosterone replacement therapy has been much debated in recent months, in light of two studies linking the treatment to increased risk of all-cause mortality, myocardial infarction, and stroke, prompting an FDA investigation into TRT’s safety and widespread criticism from members of the urologic community. In this article, Ajay Nehra, MD, discusses those studies, evolving attitudes toward “low T,” and the importance of individualizing treatment.

The “embarrassment of riches” of therapeutic options for advanced prostate cancer fortunately continues, encouraging us all to strive for lessening the incidence and impact of prostate cancer-specific mortality.

Men are being too easily enticed lately into ill-advised use of testosterone supplementation. Even men with only minimal, vague complaints are promised a hormonal fountain of youth and ageless virility. Many potential candidates seem to be under the misconception that “T” replacement will boost or energize their natural testicular production. In fact, exogenous testosterone suppresses testicular function.

In malpractice cases that involve the occurrence of a known complication during a procedure, the issues usually raised are informed consent for the procedure and the timely recognition and appropriate treatment of the complication.

Other questions addressed in this installment of "Coding Q&A" include understanding the Physician Quality Reporting System and avoiding being denied payment for lab tests based on medical necessity.

Important developments that could have an impact on urology practices include an attempt by the Centers for Medicare & Medicaid Services to provide more flexibility for providers in how they use certified EHR technology to meet meaningful use requirements and be eligible for program payments as well as proposed revisions to the FDA's “Guidance for Industry: Distributing Scientific and Medical Publications on Unapproved New Uses-Recommended Practices.”

In the August 2014 installment of "Speak Out," urologists weigh the pros and cons of shortening medical training.

By their very nature, financial markets rise and fall constantly, with an ever-present potential for gain or loss. The key is to have a plan in place in advance of large market selloffs or large market increases.

Web analytics refers to collecting, analyzing, and using data about how users interact with your website to optimize that interaction for the benefit of your business. Here is what you need to know.

Increasing daily temperature appears to be associated with an increased risk of kidney stones, results of a recently published multicenter study suggest.

Diagnosing physicians-urologists in particular-significantly influence decision making in men with low-risk prostate cancer as well as the type of treatment selected, according to researchers from The University of Texas MD Anderson Cancer Center in Houston.

Urologist Christine N. Lajeunesse, MD, who survived the shooting at Urology Nevada 7 months ago, tells a local TV station that her recovery is progressing and that she’s only angry she didn't get to tell the shooter “that he missed.”

In our “Best of AUA” report, Urology Times’ editors and writers present the AUA annual meeting’s take-home messages in 15 therapeutic areas.

Androgen deprivation therapy provides no survival benefit in older men with localized prostate cancer at 15 years, newly published research shows.

The widespread diffusion of minimally invasive robotic surgery for prostate cancer has been associated with an increase in the risk of adverse events, according to a recent study.

Philippe E. Spiess, MD, MS, presents the take home messages on penile, testis, and urethral cancer from the AUA annual meeting in Orlando, FL.

Andrew C. Peterson, MD, presents the take home messages on trauma/reconstruction/diversion from the AUA annual meeting in Orlando, FL.